Antibody News and Research

RSS
An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Further Reading

Beta-amyloid deposits found in young patients with COVID-19

Beta-amyloid deposits found in young patients with COVID-19

Heterologous vaccine schedule provides extraordinary response to third dose of coronavirus vaccines

Heterologous vaccine schedule provides extraordinary response to third dose of coronavirus vaccines

Third dose of BNT162b2 vaccine protects against Omicron hospitalizations

Third dose of BNT162b2 vaccine protects against Omicron hospitalizations

Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Humoral correlate of protection for SARS-CoV-2 may reduce COVID-19 infection risk

Humoral correlate of protection for SARS-CoV-2 may reduce COVID-19 infection risk

Development of synthetic molecules that can bridge T cells with SARS-CoV-2 infected cells

Development of synthetic molecules that can bridge T cells with SARS-CoV-2 infected cells

Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

Impact of a third BNT162b2 dose on SARS-CoV-2 Omicron variant

Impact of a third BNT162b2 dose on SARS-CoV-2 Omicron variant

Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination

Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination

Protection against SARS-CoV-2 Omicron afforded by Pfizer-BioNTech and Moderna boosters compared to two-dose primary series

Protection against SARS-CoV-2 Omicron afforded by Pfizer-BioNTech and Moderna boosters compared to two-dose primary series

Scientists develop a model to rapidly identify vaccine breakthrough SARS-CoV-2 variants

Scientists develop a model to rapidly identify vaccine breakthrough SARS-CoV-2 variants

Sensitivity and specificity of a “spit and mail” SARS-CoV-2 serology test

Sensitivity and specificity of a “spit and mail” SARS-CoV-2 serology test

LA County study finds COVID-19 'herd immunity' unlikely

LA County study finds COVID-19 'herd immunity' unlikely

Current vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2 variants

Current vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2 variants

Peptide-enhanced antibody therapy may help treat breast cancer metastasis to bone

Peptide-enhanced antibody therapy may help treat breast cancer metastasis to bone

Antibody response 18 months after SARS-CoV-2 infection in vaccinated and unvaccinated individuals

Antibody response 18 months after SARS-CoV-2 infection in vaccinated and unvaccinated individuals

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Vaccine wars ignite in California as lawmakers seek stronger laws

Vaccine wars ignite in California as lawmakers seek stronger laws

Researchers are in the race to beat Omicron

Researchers are in the race to beat Omicron

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective